Sequential therapy with cyclosporine and adalimumab in patients with severe plaque psoriasis: a series of five cases

被引：0
|
作者：
Gattu, S. [1 ,2 ]
Wu, J. J. [3 ]
Koo, J. Y. [2 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Kaiser Permanente Med Ctr, Los Angeles, CA 90034 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2009年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
275
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis
    Gniadecki, R.
    Leonardi, C. L.
    Gordon, K. B.
    Gu, Y.
    Geng, Z.
    Nader, A.
    Teixeira, H. D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (08) : 1297 - 1304
  • [32] Comparative effectiveness of Adalimumab and Etanercept in patients with chronic plaque psoriasis
    Wilson, J. L.
    Standfield, L.
    Paech, D.
    Sunduram, M.
    Mulani, P.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 : 54 - 54
  • [33] Severe plaque psoriasis with coexisting cicatricial alopecia treated with adalimumab case report
    Krasowska, Dorota
    Adamczyk, Michal
    Michalska-Jakubus, Malgorzata
    Pietrzak, Aldona
    PRZEGLAD DERMATOLOGICZNY, 2014, 101 (01): : 46 - 49
  • [34] Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis
    Ovejero-Benito, Maria C.
    Prieto-Perez, Rocio
    Llamas-Velasco, Mar
    Munoz-Aceituno, Ester
    Reolid, Alejandra
    Saiz-Rodriguez, Miriam
    Belmonte, Carmen
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Cabaleiro, Teresa
    Dauden, Esteban
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2018, 19 (01) : 7 - 16
  • [35] Patient reported health outcomes and non-adherence in psoriasis patients receiving adalimumab or ustekinumab for moderate to severe plaque psoriasis
    Goren, Amir
    Carter, Chureen
    Lee, Seina
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (01) : 43 - 50
  • [36] Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients
    Borghi, Alessandro
    Corazza, Monica
    Mantovani, Lucia
    Bertoldi, Alberto Maria
    Giari, Silvia
    Virgili, Annarosa
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (12) : 1512 - 1516
  • [37] RESISTANT SEVERE PSORIASIS CONTROLLED WITH SYSTEMIC CYCLOSPORINE THERAPY
    PICASCIA, DD
    GARDEN, JM
    FREINKEL, RK
    ROENIGK, HH
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (03) : 58 - 62
  • [38] IS CYCLOSPORINE BLOOD-CONCENTRATION MONITORING NECESSARY IN PATIENTS TREATED FOR SEVERE CHRONIC PLAQUE FORM PSORIASIS
    LINDHOLM, A
    ZACHARIAE, H
    REITAMO, S
    IBSEN, HH
    OXHOLM, A
    REUNALA, T
    JANSEN, C
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (03) : 1293 - 1295
  • [39] Pharmacokinetics of infliximab in patients with severe plaque psoriasis
    Zhu, YW
    Graham, M
    Menter, A
    Gottlieb, AB
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P158 - P158
  • [40] Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice
    Bohinc, Masa
    Branisteanu, Daciana Elena
    Khobzey, Kuzma
    Kingo, Kulli
    Pavlovsky, Lev
    Pec, Juraj
    Szegedi, Andrea
    Miljkovic, Jovan
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S33 - S33
12345